Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Hitachi High-Tech America, Inc., a subsidiary of Hitachi Ltd., is an American company located in Schaumburg, IL, that manufactures semiconductor manufacturing equipment, industrial equipment & electronic devices.

Triad Therapeutics was founded in April 1998 as Triad Biotechnology by scientists Stephen Coutts and Dan Sem and venture capitalist John Freund. In June 1999, Lin Yu and Rick Jack joined the Company as co-founders\nTriad Therapeutics, Inc. developed and manufactured drugs. It focused on generating highly potent and specific drug candidates by integrating structural biology, medicinal chemistry to accelerate discovery and development of potent, small molecule drugs. The company also provided high-affinity, nanomolar chemical lead compounds to pharmaceutical and biotechnology industries. It was founded in 1998 and was headquartered in San Diego, CA.

Compugen is a drug and diagnostic discovery company providing novel product candidates addressing important unmet therapeutic and diagnostic needs to pharmaceutical, biotech and diagnostic companies under milestone and royalty bearing, or other revenue sharing agreements. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts consist of in silico (by computer) hypothesis-driven product candidate prediction and selection followed by in vitro and in vivo experimental validation. Compugen's unique in silico prediction and selection capabilities are based on a broad and continuously growing infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology tools. Industry collaborations may be entered into before product candidate discovery is undertaken pursuant to "discovery on demand" type arrangements, or with respect to existing product candidates, can be initiated prior to, or at the proof of concept stage, or after selected preclinical activities have been undertaken by Compugen. In 2002, Compugen established an affiliate, Evogene Ltd. (TASE: EVGN.TA) - to utilize certain of the Company's in silico predictive discovery capabilities in agricultural biotechnology.

Beijing Bytedance Network Technology Co., Ltd. is a Chinese private company that provides technology solutions.

Beijing Hope Group Biotechnology Co., Ltd., established on 2014-06-25, Business scope includes biomedical,biological reagent,Technology development for genetic testing,technical consulting,Technical Services;software development;data processing(onlyPUEvalue in1.5the following);Medical Research and Experimental Development;selling computers,Software and Auxiliary Equipment,biological reagent(Free of Hazardous Chemicals),electronic product;Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Bright Dairy Co., Ltd. engages in dairy services. It offers farm management, dairy breeding, dairy feed, consumables and custody services. The company was founded on May 19, 2003 and is headquartered in Shanghai, China.

Syn X Pharma, Inc. develops diagnostic and risk management test. The company was founded by Yahia A. Gawad and George Jackowski and is headquartered in Toronto, Canada.

THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products and in the provision of genome sequencing services. It operates through the following business divisions: Pharmaceutical, Specialized drug distribution, Healthcare and Genome. It offers cimetidine tabs, dimetal tabs, gabamin tabs, aclfen tab, hydone tab, other pharmaceutical products and genome analysis services. The company was founded on September 27, 1990 and is headquartered in Ansan-si, South Korea.

Invites Healthcare Co., Ltd. engages in providing health care operation solutions. The company was founded on December 11, 2019 and is headquartered in Seoul, South Korea.

Guangzhou Jinyu Translational Medicine Research Institute Co., Ltd., established on 2016-07-20, Business scope includes research in health science projects,to develop;Medical Research and Experimental Development;Gene drug development;Technology Promotion of Research Results of Health Science Projects;Biotechnology Extension Services;

Hangzhou Lianchuan Gene Diagnostic Technology Co., Ltd., established on 2016-09-18, Business scope includes technology development,Technical Services:genetic diagnosis technology,Biotechnology(The above excludes pharmaceutical and medical services);Achievement transfer:biomedical technology,medical products(The above excludes pharmaceutical and medical services);wholesale,retail:experiment apparatus,laboratory consumables(Except for the above dangerous chemicals and precursor chemicals),medical instruments(First,Class III medical devices);Import and export(law,Except for items prohibited by administrative regulations,law,According to the administrative regulations, the projects that are currently operating can only be operated after obtaining a license).

Guangdong Boao Medical Laboratory Co., Ltd., established on 2015-04-01, Business scope includes medical services;Medical Research and Experimental Development;medical technology development,Technical Services,technology transfer;Medical equipment rental service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Lake Bell Information Technology Co., Ltd., established on 2017-01-05, Business scope includes computer information technology,electronic product,Technology development of security technology,technology transfer,technical consulting,Technical Services;Sales of computer hardware and software,technology development,technology transfer,Technical Services;R&D of electronic components,Sales,technical consulting,Technical Services;Weak current project;computer system integration;graphic design.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Theragen Bio offers a software platform for NGS and genome and transcriptome analysis. The business offers next-generation sequencing equipment like the NovaSeq 6000, HiSeq 4000, Ion S5 XL, Ion proton, Ion PGM, and MiSeqDx. The company uses QuanStudio, Fludigm, BeadXpress, GeneTitan, and LC480 as its genotyping platforms. It provides services for research, diagnostics, and healthcare.

Hitachi High-Tech Corp. engages in the manufacture and sale of electronics. It operates through the following segments: Science and Medical Systems, Electronic Device Systems, Industrial Systems, Advanced Industrial Products, and Others. The Science and Medical Systems segment includes electron microscopes and scientific and analytical instruments such as spectrophotometer, chromatograph, and thermal analysis. The Electronic Device Systems segment manufactures and sells semiconductor manufacturing equipment such as etching and visual inspection equipment, and CD-SEMs(Critical Dimension Scanning Electron Microscopes). The Industrial Systems segment offers wire inspection equipment for railway operation, automated assembly systems for automotive components, and Internet of Things (IoT) solutions. The Advanced Industrial Products segment deals with industrial materials, optical devices and electronic device materials. The Others segment handles businesses of indirect subsidiaries. The company was founded on April 12, 1947 and is headquartered in Tokyo, Japan.

Majorbio offers gene sequencing and analysis service. Their cloud platforms gadgets such as limma difference analysis, violin diagram, primer design, pcoa, kegg compound classification, venn analysis, statistical analysis, km survival analysis curve, anti smash, roc analysis line chart, wgcna analysis, and outlier handling.

Shanghai Guanan Information Technology Co. Ltd. (doing business as Information & Data Security Solutions Co., Ltd) is a company headquartered in Shanghai, China, that provides data security services. It was founded in 2013 by Shao Hu.